🔗 Visit the ClinicalTrials.gov page for NCT00600496
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. | Oncotarget | 2014 | 1.34 |
| 2 | Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. | Cancer | 2012 | 1.32 |
| 3 | Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma. | Target Oncol | 2011 | 0.75 |